The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Inactivated Polio Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
The global Inactivated Polio Vaccine market size is expected to reach US$ 926.8 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Inactivated Polio Vaccine in various end use industries. The expanding demands from the Pediatrics and Adults, are propelling Inactivated Polio Vaccine market. Government, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Private Sector segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inactivated Polio Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inactivated Polio Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inactivated Polio Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inactivated Polio Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inactivated Polio Vaccine covered in this report include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
The global Inactivated Polio Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Inactivated Polio Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inactivated Polio Vaccine market, Segment by Type:
Government
Private Sector
Global Inactivated Polio Vaccine market, by Application
Pediatrics
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inactivated Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inactivated Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
The global Inactivated Polio Vaccine market size is expected to reach US$ 926.8 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Inactivated Polio Vaccine in various end use industries. The expanding demands from the Pediatrics and Adults, are propelling Inactivated Polio Vaccine market. Government, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Private Sector segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inactivated Polio Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inactivated Polio Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inactivated Polio Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inactivated Polio Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inactivated Polio Vaccine covered in this report include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
The global Inactivated Polio Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Inactivated Polio Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inactivated Polio Vaccine market, Segment by Type:
Government
Private Sector
Global Inactivated Polio Vaccine market, by Application
Pediatrics
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inactivated Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inactivated Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Inactivated Polio Vaccine Market Overview
1.1 Inactivated Polio Vaccine Product Overview
1.2 Inactivated Polio Vaccine Market Segment by Type
1.2.1 Government
1.2.2 Private Sector
1.3 Global Inactivated Polio Vaccine Market Size by Type
1.3.1 Global Inactivated Polio Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Inactivated Polio Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inactivated Polio Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inactivated Polio Vaccine Sales Breakdown by Type (2018-2023)
2 Global Inactivated Polio Vaccine Market Competition by Company
2.1 Global Top Players by Inactivated Polio Vaccine Sales (2018-2023)
2.2 Global Top Players by Inactivated Polio Vaccine Revenue (2018-2023)
2.3 Global Top Players by Inactivated Polio Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Inactivated Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inactivated Polio Vaccine Market Competitive Situation and Trends
2.5.1 Inactivated Polio Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inactivated Polio Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Inactivated Polio Vaccine Market
2.8 Key Manufacturers Inactivated Polio Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inactivated Polio Vaccine Status and Outlook by Region
3.1 Global Inactivated Polio Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Polio Vaccine Historic Market Size by Region
3.2.1 Global Inactivated Polio Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Inactivated Polio Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Inactivated Polio Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inactivated Polio Vaccine Forecasted Market Size by Region
3.3.1 Global Inactivated Polio Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Inactivated Polio Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Inactivated Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inactivated Polio Vaccine by Application
4.1 Inactivated Polio Vaccine Market Segment by Application
4.1.1 Pediatrics
4.1.2 Adults
4.2 Global Inactivated Polio Vaccine Market Size by Application
4.2.1 Global Inactivated Polio Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Inactivated Polio Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inactivated Polio Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inactivated Polio Vaccine Sales Breakdown by Application (2018-2023)
5 North America Inactivated Polio Vaccine by Country
5.1 North America Inactivated Polio Vaccine Historic Market Size by Country
5.1.1 North America Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
5.2 North America Inactivated Polio Vaccine Forecasted Market Size by Country
5.2.1 North America Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
6 Europe Inactivated Polio Vaccine by Country
6.1 Europe Inactivated Polio Vaccine Historic Market Size by Country
6.1.1 Europe Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Inactivated Polio Vaccine Forecasted Market Size by Country
6.2.1 Europe Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Inactivated Polio Vaccine by Region
7.1 Asia-Pacific Inactivated Polio Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inactivated Polio Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inactivated Polio Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inactivated Polio Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Inactivated Polio Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inactivated Polio Vaccine Sales in Value by Region (2024-2029)
8 Latin America Inactivated Polio Vaccine by Country
8.1 Latin America Inactivated Polio Vaccine Historic Market Size by Country
8.1.1 Latin America Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Inactivated Polio Vaccine Forecasted Market Size by Country
8.2.1 Latin America Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Inactivated Polio Vaccine by Country
9.1 Middle East and Africa Inactivated Polio Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Inactivated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inactivated Polio Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inactivated Polio Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inactivated Polio Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Inactivated Polio Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inactivated Polio Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Inactivated Polio Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Inactivated Polio Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Bibcol
10.3.1 Bibcol Company Information
10.3.2 Bibcol Introduction and Business Overview
10.3.3 Bibcol Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bibcol Inactivated Polio Vaccine Products Offered
10.3.5 Bibcol Recent Development
10.4 Serum Institute
10.4.1 Serum Institute Company Information
10.4.2 Serum Institute Introduction and Business Overview
10.4.3 Serum Institute Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Serum Institute Inactivated Polio Vaccine Products Offered
10.4.5 Serum Institute Recent Development
10.5 Tiantan Biological
10.5.1 Tiantan Biological Company Information
10.5.2 Tiantan Biological Introduction and Business Overview
10.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tiantan Biological Inactivated Polio Vaccine Products Offered
10.5.5 Tiantan Biological Recent Development
10.6 Panacea Biotec
10.6.1 Panacea Biotec Company Information
10.6.2 Panacea Biotec Introduction and Business Overview
10.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Panacea Biotec Inactivated Polio Vaccine Products Offered
10.6.5 Panacea Biotec Recent Development
10.7 Bio-Med
10.7.1 Bio-Med Company Information
10.7.2 Bio-Med Introduction and Business Overview
10.7.3 Bio-Med Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bio-Med Inactivated Polio Vaccine Products Offered
10.7.5 Bio-Med Recent Development
10.8 Halfkin Bio-Pharmaceuticals
10.8.1 Halfkin Bio-Pharmaceuticals Company Information
10.8.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Products Offered
10.8.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inactivated Polio Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inactivated Polio Vaccine Industrial Chain Analysis
11.4 Inactivated Polio Vaccine Market Dynamics
11.4.1 Inactivated Polio Vaccine Industry Trends
11.4.2 Inactivated Polio Vaccine Market Drivers
11.4.3 Inactivated Polio Vaccine Market Challenges
11.4.4 Inactivated Polio Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inactivated Polio Vaccine Distributors
12.3 Inactivated Polio Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
